William Desmarais
Keine laufenden Positionen mehr
Profil
William Desmarais served as Vice President-Business Development at Momenta Pharmaceuticals, Inc. from 2017 to 2021.
He then worked as Chief Business Officer at TScan Therapeutics, Inc. from 2021 to 2023.
Desmarais holds an MBA from Massachusetts Institute of Technology, a doctorate from Brandeis University, and an undergraduate degree from Purdue University.
Ehemalige bekannte Positionen von William Desmarais
| Unternehmen | Position | Ende |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.02.2021 |
Ausbildung von William Desmarais
| Brandeis University | Doctorate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
| Purdue University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
